Search for...
Add Business
Log In
Businesses
Jobs
preciese location is off
Cancel
Home
›
New York
›
New York
›
Pulmonologists
› Robert Jeffrey Kaner, M.D.
Robert Jeffrey Kaner, M.D.
be the first one to review!
(646)962-2333
verified
425 E. 61st Street 4th Floor, Suite 402
New York
NY
,
10065
425 E. 61st Street 4th Floor, Suite 402
,
New York
NY
,
10065
(646)962-2333
weillcornell.org/rjkaner?utm_source=yextnetwork&utm_medium=organic&utm_campaign=yext_doctor_listings
Pulmonologists
claim this listing
share
sms info
send invite
report a problem
Looking For Pulmonologists?
SPONSORED
About Robert Jeffrey Kaner, M.D.
Dr. Kaner is Associate Attending Physician at the NewYork-Presbyterian Weill Cornell Medical Center and Associate Professor of Clinical Medicine and Genetic Medicine at Weill Cornell Medicine. Dr. Kaner was the Principal Investigator of the Weill-Cornell Medicine site of the NIH-sponsored Idiopathic Pulmonary Fibrosis (IPF) Clinical Research Network for which he chaired the Adjudication Committee. He has extensive experience in the phenotyping of subjects with lung disease and their enrollment in research studies. He leads a monthly multidisciplinary ILD conference with Dr. William Travis (MSKCC) and Dr. Chen Zhang (WCM) for the past 15 years. He is the director of the New York Presbyterian Hospital – Weill Cornell Medicine Pulmonary Fibrosis Foundation Clinical Center of Excellence. He participates in clinical trials evaluating various pharmacologic interventions in IPF and other ILDs, sponsored by both NIH and pharma. He leads an ILD biobank, which enhances future translational research opportunities. He leads an observational study to determine the incidence and natural history of ILD following COVID-19 acute respiratory failure.Dr. Kaner chairs the bronchoscopy sub-study committee of the NHLBI SPIROMICS and SOURCE research networks, which uses RNA-sequencing to evaluate gene expression changes in lung cells associated with smoking and COPD endotypes. He is analyzing the effects of doxycycline on BAL matrix metalloproteinase (MMP) inhibition in HIV-positive individuals with early emphysema, based on his previous translational work. He is also participating in pharmacologic intervention studies in COPD and emphysema sponsored by the ALA, DOD and NIH, including leadership (with Dr. Marshall Glesby) of a Phase II multicenter trial of doxycycline to slow emphysema progression in PLWH. He is the Associate Director of the T32 training program and Associate Fellowship Program Director.
Languages Spoken:
English
Robert Jeffrey Kaner, M.D., pulmonologist, listed under "Pulmonologists" category, is located at 425 E. 61st Street 4th Floor, Suite 402 New York NY, 10065 and can be reached by 6469622333 phone number. Robert Jeffrey Kaner, M.D. has currently no reviews.
Browse all Pulmonologists
in New York NY. Discover
census data for New York, NY
.
Map To This Location
483.40 mi away
1 hour and 6 minutes by plane
Give
to Robert Jeffrey Kaner, M.D.
show
2
0
Recent Activity
Copyright © 2006-2024
SHOWMELOCAL Inc.
- All Rights Reserved. |
Made in NYC
SHOWMELOCAL®.com is Your Yellow Pages and Local Business Directory Network
SHOWMELOCAL® is a registered trademark of ShowMeLocal Inc.
×
Top